Key result
Cardiometabolic risk factors, including obesity, hypertension, and diabetes, are significantly associated with an increased risk of developing and recurring atrial fibrillation.
This review summarizes the relationship between metabolic syndrome components and the development or pathophysiology of atrial fibrillation.
Answers are grounded in this paper and cite their sources.
Supports MetS-AF association in existing data; leaves open causality and whether targeting components alters AF incidence.
Atrial fibrillation (AF) is the most common arrhythmia worldwide; it is a significant risk factor for stroke and embolization, and has an impact on cardiac function. Despite its impact on morbidity and mortality, our understanding of the etiology and pathophysiology of this disease process is still incomplete. Over the past several decades, there has been evidence to suggest that AF has a significant correlation with metabolic syndrome (MetS). Furthermore, AF appears to be more closely related to specific components of MetS compared with others. This article provides an overview of the various components of MetS and their impact on AF.
No takes yet. Share an insight, caveat, or question.
Menezes et al. (2013) conducted a review in Atrial Fibrillation and Metabolic Syndrome. Cardiometabolic risk factors (Obesity, Hypertension, Diabetes, Dyslipidemia) vs. Absence of cardiometabolic risk factors was evaluated. Cardiometabolic risk factors, including obesity, hypertension, and diabetes, are significantly associated with an increased risk of developing and recurring atrial fibrillation.
Synapse has enriched 10 related papers. Consider them for comparative context: